PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 28, 2024New England Journal of Medicine292 citations

Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis

View Full Paper
PGPhilippe GénéreuxASAllan SchwartzJOJ. Bradley Oldemeyer

Key Points

Key points are not available for this paper at this time.

Abstract

Among patients with asymptomatic severe aortic stenosis, a strategy of early TAVR was superior to clinical surveillance in reducing the incidence of death, stroke, or unplanned hospitalization for cardiovascular causes. (Funded by Edwards Lifesciences; EARLY TAVR ClinicalTrials.gov number, NCT03042104.).

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Généreux et al. (2024) studied this question.

synapsesocial.com/papers/69bd55493b1b9409a95d679dhttps://doi.org/10.1056/nejmoa2405880
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Design and rationale of the evaluation of transcatheter aortic valve replacement compared to surveillance for patients with asymptomatic severe aortic stenosis: The EARLY TAVR trial2023 · 48 citations
  2. 2Aortic valve replacement vs. conservative treatment in asymptomatic severe aortic stenosis: long-term follow-up of the AVATAR trial2024 · 67 citations
  3. 3Aortic Valve Stenosis Treatment Disparities in the Underserved2019 · 52 citations
  4. 4The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis1990 · 392 citations
  5. 5Mortality While Waiting for Aortic Valve Replacement2014 · 115 citations